Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Adrian Lankenau-Ahumada"'
Autor:
Mark S. Kim, Deanna Glassman, Katelyn F. Handley, Adrian Lankenau Ahumada, Nicholas B. Jennings, Emine Bayraktar, Katherine Foster, Robiya Joseph, Sanghoon Lee, Robert L. Coleman, Anil K. Sood
Publikováno v:
Cancer Medicine, Vol 13, Iss 15, Pp n/a-n/a (2024)
Abstract Background GP‐2250, a novel analog of taurultam (TRLT), has emerged as a potent anti‐neoplastic drug; however, the mechanisms underlying its effects are not well understood. Here, we investigated the mechanism of action and the biologica
Externí odkaz:
https://doaj.org/article/8fee05e54a2146f8a9853a7f0ad7e50c
Autor:
Sara Corvigno, Yuan Liu, Emine Bayraktar, Elaine Stur, Nazende Nur Bayram, Adrian Lankenau Ahumada, Supriya Nagaraju, Cristian Rodriguez-Aguayo, Hu Chen, Thanh Chung Vu, Yunfei Wen, Han Liang, Li Zhao, Sanghoon Lee, Gabriel Lopez-Berestein, Anil K. Sood
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-13 (2024)
Abstract Small RNAs (microRNAs [miRNAs] or small interfering RNAs [siRNAs]) are effective tools for cancer therapy, but many of the existing carriers for their delivery are limited by low bioavailability, insufficient loading, impaired transport acro
Externí odkaz:
https://doaj.org/article/087c961034464f26a8c8679bea773cfa
Autor:
Yuan Liu, Adrian Lankenau Ahumada, Emine Bayraktar, Paul Schwartz, Mamur Chowdhury, Sixiang Shi, Manu M. Sebastian, Htet Khant, Natalia de Val, Nazende Nur Bayram, Guodong Zhang, Thanh Chung Vu, Zuliang Jie, Nicholas B. Jennings, Cristian Rodriguez-Aguayo, Jody Swain, Elaine Stur, Lingegowda S. Mangala, Yutuan Wu, Supriya Nagaraju, Brooke Ermias, Chun Li, Gabriel Lopez-Berestein, Janet Braam, Anil K. Sood
Publikováno v:
Journal of Controlled Release. 357:472-483
Autor:
Yutuan Wu, Nicholas B. Jennings, Yunjie Sun, Santosh K. Dasari, Emine Bayraktar, Sara Corvigno, Elaine Stur, Deanna Glassman, Lingegowda S. Mangala, Adrian Lankenau Ahumada, Shannon N. Westin, Anil K. Sood, Wei Hu
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:803-821
Purpose Tumor-associated macrophages (TAMs) are known to contribute to adaptive resistance to anti-vascular endothelial growth factor (VEGF) antibody (AVA) therapy in ovarian cancer. BET (bromodomain and extra-terminal domain) inhibitors (BETi) may h
Autor:
Li Zhao, Sara Corvigno, Shaolin Ma, Joseph Celestino, Nicole D. Fleming, Richard A. Hajek, Adrian Lankenau Ahumada, Nicholas B. Jennings, Erika J. Thompson, Hongli Tang, Shannon N. Westin, Amir A. Jazaeri, Jianhua Zhang, P. Andrew Futreal, Anil K. Sood, Sanghoon Lee
Publikováno v:
Cancers; Volume 14; Issue 15; Pages: 3589
Patients with high-grade serous ovarian cancer (HGSC) who have no visible residual disease (R0) after primary surgery have the best clinical outcomes, followed by patients who undergo neoadjuvant chemotherapy (NACT) and have a response enabling inter
Autor:
Yuan Liu, Adrian Lankenau-Ahumada, Emine Bayraktar, Paul Schwartz, Mamur Chowdhury, Sixiang Shi, Manu M. Sebastian, Htet Khant, Natalia De Val, Zuliang Jie, Nicholas B. Jennings, Cristian Rodriguez-Aguayo, Jody Swain, Elaine Stur, Lingegowda S. Mangala, Yutuan Wu, Supriya Nagaraju, Brooke Erimas, Chun Li, Gabriel Lopez-Berestein, Janet Braam, Anil K. Sood
Publikováno v:
Cancer Research. 83:2720-2720
Plant-derived vesicles (PDVs) were attractive for therapeutic applications, including as potential nanocarriers. However, a concern with oral delivery of PDVs is whether they would remain intact in the gastrointestinal tract. We found that 82% of cab
Autor:
Yutuan, Wu, Nicholas B, Jennings, Yunjie, Sun, Santosh K, Dasari, Emine, Bayraktar, Sara, Corvigno, Elaine, Stur, Deanna, Glassman, Lingegowda S, Mangala, Adrian, Lankenau Ahumada, Shannon N, Westin, Anil K, Sood, Wei, Hu
Publikováno v:
Journal of cancer research and clinical oncology. 148(4)
Tumor-associated macrophages (TAMs) are known to contribute to adaptive resistance to anti-vascular endothelial growth factor (VEGF) antibody (AVA) therapy in ovarian cancer. BET (bromodomain and extra-terminal domain) inhibitors (BETi) may have uniq